Intra-Cellular Therapies (ITCI) – FDA
-
Intra-Cellular Therapies (ITCI) to Resume Trading at 7:30 a.m.
-
Intra-Cellular Therapies (ITCI) Reports Positive Phase 3 Topline Results from Study 501
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ITCI Stock Lookup